The pathogenicity of infection produced following intracerebral (i.c.) inoculation of wild-type vesicular stomatitis virus (VSV) or temperature-sensitive (ts) mutants of VSV was compared. ts mutants used were ts 31 (VSV complementation group II) and ts 41 (VSV complementation group IV). The i.c. injection of wild-type VSV in weanling Swiss mice produced a rapidly fatal encephalitis with death of mice in 2 to 3 days. Histopathologically, such mice exhibited minimal changes of encephalitis on light microscopy. In contrast to the highly virulent, rapidly fatal central nervous system (CNS) infection seen after i.c. inoculation of wild-type VSV, infection with ts 31 VSV produced a more slowly progressive CNS infection characterized by hind limb paralysis and death 6 to 9 days after infection. Histopathologically, CNS infection with ts 31 is associated with previously unreported extensive spongiform changes in the gray matter of the spinal cord. The inoculation of ts 41 i.c., on the other hand, did not result in either clinical illness or histopathological changes in the spinal cords or brains of infected mice. The absence of clinical and histopathological lesions following i.c. infection ofts 41 VSV suggests that the capacity to alter the pathogenesis of VSV CNS infection may be a function of only certain ts mutants of VSV.
Considerable investigative effort has been directed at defining mechanisms that explain the nature of persistent virus infection. A number of the studies have used carrier cell cultures as models of persistent virus infection (8, 13) . Many viruses, even some considered highly cytocidal, can establish infection of cell cultures which result in persistent virus multiplication while the cell culture continues to survive and grow (13) . Such cell cultures which continue to grow and survive after establishment of viral infection are defined as carrier cultures. One of the more important mechanisms by which persistently infected carrier cultures are maintained is through the selection or evolution of temperature-sensitive (ts) mutants in cell cultures (8) . In spite of the extensive body of data concerning the role ts mutants play in vitro, little is known of their role, if any, in disease production in vivo.
Recently, Holland and Villarreal (4) described a carrier culture model involving vesicular stomatitis virus (VSV). VSV infection of cells is usually highly cytocidal, with death of the cells in less than 24 h. But, by infecting cells with both defective-interfering (DI) particles of ts 31 and standard ts 31 VSV particles, a chronic carrier culture was established. Furthermore, DI particles generated during the establishment of chronic ts 31 VSV infection in vitro, mixed even with highly virulent wildtype (wt) VSV, could now be used to establish carrier cultures. Because of these studies, we considered it worthwhile to explore the possibility that certain ts mutants of VSV could alter the usually highly virulent central nervous system (CNS) disease produced by wt VSV infection of mice into a more slowly progressive infection. The purpose of these studies was, therefore, to describe the in vivo CNS disease produced after intracerebral (i.c.) inoculation of wt or certain ts mutants of VSV.
Our results suggest that in contrast to wt VSV, CNS infection produced after i.c. inoculation of ts 31 is slowly progressive and associated with previously unreported spongiform changes in the gray matter of the spinal cord. In contrast, i.c. infection with ts 41 results in neither clinical signs nor histological lesions in the CNS. (9, 11) . Each of these mutants was plaque purified in Reichmann's laboratory and subsequently passaged by infecting cells with 0.01 to 0.1 PFU/cell to minimize production of DI particles of the ts mutants. ts 31 is a member of complementation group III (11) and ts 41 is a member of complementation group IV (11 5 .55 x 108 PFU/ml.
Plaque assay. BHK-21 cells (5.0 x 10; to 7.5 x 10'/ ml) were cultured in six-well plates (35 by 10 mm, FB-6TC, Linbro Co., New Haven, Conn.) in 2 ml of BHK-21 growth medium. Confluent monolayers developed in 24 to 36 h and were infected by adding 0.1-ml log,,, dilutions of freshly thawed virus stock to each series of wells. Virus was allowed to adsorb for 60 min at either 31 or 37 C in a 5% CO2 atmosphere, and wells were overlayed with 2 ml of Eagle basal medium supplemented with 5% fetal calf serum, 5% (wt/vol) tryptose phosphate, 2 mM L-glutamine, 100 U of penicillin, 100 ,g of streptomycin, 2.5 ,ug of amphotericin B, and 0.7% lonagar (Colab Labs, Chicago). Virus samples were then grown at 31 C for fluids containing ts mutants and 37 C for fluids containing wt VSV. After incubation for 24 h at the appropriate temperatures, cultures were counterstained with a second overlay containing neutral red (1:9,000). All samples were plaqued in triplicate, and plaques were counted 18 h after the second overlay by inverting the plates over an X-ray viewbox.
Ultraviolet inactivation of VSV. The ts 31 VSV was placed in a 100-mm sterile tissue culture dish and irradiated by a Sylvania germicidal lamp, G15T8, at a distance of 8 cm for 10 min with constant swirling. After ultraviolet (UV) inactivation, aliquots of ts 31 were either plaqued at 31 C in BHK-21 cells or grown in 25-cm2 flasks of BHK-21 cells in an attempt to determine whether any residual virus remained. No residual infectious virus was detected by either method.
Hyperimmune serum. Doubly cloned wt VSV was used to raise antibody in rabbits. Before injection, three rabbits were bled from the ear, and the sera were separated and then stored at -20 C. These control sera tested individually were shown to contain <1:10 titer of neutralizing antibody to VSV. These rabbits were then injected with 108 PFU of wt VSV intravenously via the ear veins. VSV-injected rabbits were boosted intravenously weekly for 5 consecutive weeks with 108 PFU of VSV. Two weeks after the last inoculation of VSV, rabbits were exsanguinated and the sera were pooled and titered for neutralizing antibody by standard plaque reduction. The pooled serum was shown to have a neutralizing antibody titer of 1:64,000.
Histopathological studies. Mice were anesthetized by intraperitoneal injection of 0.02 ml of Diabutal (50 mg/ml) and sacrificed by total body perfusion with cold (4 C) 3% glutaraldehyde in phosphate buffer (pH 7.4 
RESULTS
Initial experiments compared the susceptibility of weanling mice (Swiss, 3 to 4 weeks old) to infection with wt, ts 31, and ts 41 VSV. Groups of 6 to 10 mice were injected with log,,) dilutions of each virus preparation i.c., and the 50% mean lethal dose was determined by the method of Reed and Muench (10) . Table 1 compares the amounts of virus required to cause death from infection when the three VSV preparations were administered by the i.c. route. The mean lethal dose for wt VSV was 50 PFU, whereas ts 31 required 500 PFU. In contrast, ts 41 was avirulent even by the i.c. route. Although not shown, intraperitoneal inoculation of these three VSV preparations did not result in death of the mice, with the exception of occasional deaths in the wt VSV-infected group. Thus, although wt VSV is virulent for mice after i.c. inoculation, it has very limited virulence when administered by a peripheral route of challenge even in doses as large as 108 PFU.
Clinically, wt VSV injected i.c. produced a rapidly fatal disease with mice dying 2 to 3 days after infection (Table 2 ). Mice rarely survived 4 days after wt VSV infection. This clinical picture was consistent and reproducible over a wide dose range (2.5 x 102 to 10" PFU of wt VSV i.c.). Mice infected with wt VSV exhibited ruffled fur and lethargy before death. In our experiments, we were impressed by the absence of overt paralysis or convulsions except as a preterminal event (Table 2 ). In contrast to wt VSV infection, mice injected with 104 PFU of ts 31 i.c. survived 6 to 9 days, with the majority of mice dying by 7 days after infection. Clinically, all mice infected i.c. with ts 31 exhibited marked wasting and hind limb paralysis (Table  2 ). Mice would sometimes move about the cage, (Table 2 ). Thus, mice survived i.c. challenge with ts 41 and remained well. Although not depicted, challenge of ts 41-infected mice 21 days after inoculation with 104 PFU of wt VSV resulted in survival of six of eight mice. These results suggest that i.c. inoculation of ts 41 probably results in some replication of ts 41 in these mice. Furthermore, preliminary studies have demonstrated ts 41 virus in mouse brains 4 to 6 days after i.c. inoculation. Titers of virus were 10: to 10) log,,, PFU per ml of brain (unpublished data).
Mice infected i.c. with wt VSV, ts 31, and ts 41 were next studied histologically to define the development of pathological changes seen after infection. One day after mice were infected with wt VSV i.c., brains and spinal cords were normal. Two days after infection, however, brains of wt VSV-infected mice demonstrated very rare foci of parenchymal necrosis and more frequent foci of perivascular mononuclear cell infiltration (Fig. 1) . These changes were 4 days after infection. In addition, mononuclear cell infiltrates were also seen around the lateral ventricles, especially in areas where the ependymal lining appeared dark and shrunken in appearance. Most striking, however, were the spinal cord lesions seen in ts 31-infected mice. By 4 days after infection, the ependymal cells of the central canal had lost their cilia, appeared dark and shrunken, and often were frankly necrotic. Most unexpected, however, were the striking spongiform changes evident in the gray matter of the spinal cords by 4 days after infection. At this time, the spongiform changes were localized to the anterior horns. By 5 days after infection the spongiform changes were more extensive, being present throughout gray matter of the spinal cord (Fig. 2) . These spongiform changes were due to dilatation principally of perivascular ( Fig. 3 and 4 ) and perineuronal processes (Fig. 4) , although other areas of the neuropil were also affected. Swollen processes could reach considerable dimensions, often exceeding the size of large neurons. Little inflammation accompanied the spongiform changes initially (4 days), but by 5 days after infection mononuclear cell infiltration was evident. The white matter of the spinal cord was unremarkable and no intracytoplasmic or intranuclear inclusion bodies were observed. Preliminary ultrastructural studies suggested that these enlarged, swollen processes were mainly of astrocytic and dendritic origin.
Light and electron microscope examinations were also performed for mice infected i.c. with ts 41 VSV. Brains and spinal cords were examined 4 and 8 days after infection and appeared entirely normal. Thus, after i.c. inoculation of ts 41 no pathological lesions were evident.
DISCUSSION
The i.c. injection of wt VSV produces a rapidly fatal encephalitis with death of mice in 2 to 3 days. Histologically, such mice exhibit minimal changes of encephalitis (Fig. 1) . These changes include rare areas of parenchymal necrosis and more frequent foci of mononuclear cell infiltration surrounding small vessels in the brain. In contrast to the highly virulent, rapidly fatal CNS infection seen after i.c. inoculation of wt VSV, infection with ts 31 VSV produced a slowly progressive CNS infection characterized by previously unreported spongiform myelopathy (Table 2 and Fig. 2-4 neither clinical illness nor histopathological lesions (Table 2) . Thus, the slowly progressive CNS disease and spongiform myelopathy seem associated with the host-parasite relationship established with this ts mutant of VSV.
Several reservations, however, must be raised in this regard. First, it is not clear from our studies that wt VSV-infected mice would not develop the histopathological changes observed after infection with ts 31 if the mice survived longer than 2 to 3 days. Thus, although we have never observed spongiform myelopathy in weanling Swiss mice infected i.c. with wt VSV, we cannot be sure that the spongiform changes would not occur with wt VSV infection. Although these spongiform changes may occur with wt VSV infection, previous studies on the histopathological changes seen in the CNS with wt VSV infection do not report such findings (7) . Second, preliminary work with another ts mutant of VSV (ts 22, complementation group II) suggests that this mutant may also be associated with slowly progressive CNS disease and spongiform myelopathy (unpublished data). Thus, it is not entirely clear at this time whether the slowly progressive CNS disease and spongiform lesions are unique to the ts 31 mutant of VSV or whether other ts mutants of VSV also have this capability. What is clear, however, is that the ts 31 mutant of VSV, and perhaps other ts mutants, possesses the capability of radically altering CNS disease usually associated with VSV infection. In addition, the ts mutants appear capable of producing histopathological lesions which have some similarities to the so-called slow viral diseases such as Creutzfeldt-Jakob disease, Kuru, and scrapie (1, 5 Finally, these studies suggest that use of ts mutants as vaccines may be associated with significant hazards. Use of such ts mutants has already been reported for influenza (6) and respiratory syncytial virus (2) . Use of such mutants has a number of theoretical advantages, including their ability to replicate to high titer at permissive temperatures (31 to 33 C) but only to a limited extent at nonpermissive temperatures (37 to 39 C). In addition, replication of these mutants at permissive temperatures to high titer assures synthesis of viral proteins in sufficient concentration to allow substantial host immune reponses to occur. Such host responses are essential to active sensitization and the desired result of long-lasting and durable immune responses. The major problem associated with use of these ts mutants is that they have not been genetically characterized. Thus, serious questions must be raised with regard to their genetic stability and, hence, safety. Our studies also suggest that for at least VSV, certain ts mutants may be associated with a significantly altered clinical illness from that seen with ordinary wt infection. These observations raise the question as to whether ts mutants might not also have an important role to play in vivo in slowly progressive or unusual viral syndromes.
